Literature DB >> 14576433

The BRCT domain is a phospho-protein binding domain.

Xiaochun Yu1, Claudia Christiano Silva Chini, Miao He, Georges Mer, Junjie Chen.   

Abstract

The carboxyl-terminal domain (BRCT) of the Breast Cancer Gene 1 (BRCA1) protein is an evolutionarily conserved module that exists in a large number of proteins from prokaryotes to eukaryotes. Although most BRCT domain-containing proteins participate in DNA-damage checkpoint or DNA-repair pathways, or both, the function of the BRCT domain is not fully understood. We show that the BRCA1 BRCT domain directly interacts with phosphorylated BRCA1-Associated Carboxyl-terminal Helicase (BACH1). This specific interaction between BRCA1 and phosphorylated BACH1 is cell cycle regulated and is required for DNA damage-induced checkpoint control during the transition from G2 to M phase of the cell cycle. Further, we show that two other BRCT domains interact with their respective physiological partners in a phosphorylation-dependent manner. Thirteen additional BRCT domains also preferentially bind phospho-peptides rather than nonphosphorylated control peptides. These data imply that the BRCT domain is a phospho-protein binding domain involved in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576433     DOI: 10.1126/science.1088753

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  377 in total

1.  Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway.

Authors:  Y Jia; W Song; F Zhang; J Yan; Q Yang
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

2.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

3.  TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.

Authors:  Kang Liu; Yuhong Luo; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

4.  Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.

Authors:  Caroline M S Ekblad; Assaf Friedler; Dmitry Veprintsev; Richard L Weinberg; Laura S Itzhaki
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

Review 5.  BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.

Authors:  Seth M Dever; E Railey White; Matthew C T Hartman; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

6.  Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.

Authors:  Kirsty M Brodie; Beric R Henderson
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 7.  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Authors:  Arun Gupta; Clayton R Hunt; Sharmistha Chakraborty; Raj K Pandita; John Yordy; Deepti B Ramnarain; Nobuo Horikoshi; Tej K Pandita
Journal:  Radiat Res       Date:  2013-12-09       Impact factor: 2.841

8.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

9.  The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1.

Authors:  Sinny Delacroix; Jill M Wagner; Masahiko Kobayashi; Ken-ichi Yamamoto; Larry M Karnitz
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

10.  Negative Regulation of AKT Activation by BRCA1.

Authors:  Tao Xiang; Amiko Ohashi; Yuping Huang; Tej K Pandita; Thomas Ludwig; Simon N Powell; Qin Yang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.